| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President Of R&D | Director | President +4 more
2 companies
Vaishnaw Akshay is a President Of R&D at SRRK with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 32 sells.
Estimated insider holdings value: $34.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | President, R&D | Sale+OE | 970 | $151.07 | $146,535.74 | -1.3% | |
| Apr 20, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | President, R&D | Sale+OE | 21,971 | $140.00 | $3,075,940.00 | -60.9% | |
| Feb 7, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | President, R&D | Sale+OE | 23,708 | $125.00 | $2,963,500.00 | -67.9% | |
| Mar 14, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | President, R&D | Sale+OE | 88,554 | $143.10 | $12,672,126.11 | -23.1% | |
| Oct 30, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, R&D | Sale+OE | 33,666 | $121.46 | $4,088,967.46 | -24.4% | |
| May 23, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, R&D | Sale+OE | 11,000 | $75.00 | $825,000.00 | -51.7% | |
| May 15, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, R&D | Sale+OE | 43,750 | $65.00 | $2,843,750.00 | -68.0% | |
| Nov 30, 2016 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, R&D, CMO | Sale+OE | 29,165 | $44.99 | $1,311,997.85 | -46.5% | |
| Jun 16, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, R&D, CMO | Sale+OE | 8,750 | $128.83 | $1,127,238.77 | -54.5% | |
| Mar 17, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, R&D, CMO | Sale+OE | 8,750 | $116.86 | $1,022,568.36 | -39.3% |